Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Exercise/Conversion of 4,000 SEPN shares, $27.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Septerna, Inc. (SEPN) | Exercise/Conversion | 4,000 | $27.2K |
| Aug 13, 2026 | Septerna, Inc. (SEPN) | Exercise/Conversion | 18,681 | $127.2K |
| Jul 17, 2026 | Septerna, Inc. (SEPN) | Exercise/Conversion | 4,000 | $27.2K |
| Apr 17, 2026 | Septerna, Inc. (SEPN) | Exercise/Conversion | 4,000 | $27.2K |
| Feb 20, 2026 | Septerna, Inc. (SEPN) | Exercise/Conversion | 4,000 | $27.2K |
| Feb 11, 2026 | Septerna, Inc. (SEPN) | Grant/Award | 155,000 | n/a |
| Aug 11, 2025 | Septerna, Inc. (SEPN) | Grant/Award | 95,000 | n/a |
| Jun 13, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 800 | n/a |
| Feb 21, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 2,000 | n/a |
| Jun 22, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 20,000 | n/a |